Chronic Pain Clinical Trial
— ALGEAOfficial title:
An Innovative Psychosocial Intervention for the Treatment of Chronic Pain Patients and Their Families
| Verified date | May 2016 |
| Source | University of Cyprus |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Cyprus: Cyprus National Bioethics Committee |
| Study type | Interventional |
Chronic pain is a long-term condition which is related to a number of negative consequences
including reduced productivity at work, increased number of sick leave , depression and
emotional difficulties among others. Psychological interventions, particular Cognitive
Behavioral therapies (CBT) are deemed effective in reducing the negative consequences
following a diagnosis of a chronic pain condition. Though research provides substantial
evidence for the CBT effectiveness, not all patients manage to reduce pain intensity or
improve their physical and psychosocial functioning. Also, CBT appears with only small
effect sizes on variables considered to be core domains in chronic pain. Finally, there are
criticism targets on the lack of clear mechanisms underlying the process of change in CBT.
New CBT therapeutic approaches, such as Acceptance and Commitment Therapy (ACT) focus on
changing individuals' relation with their inner experiences. They utilize mindfulness and
acceptance processes, instead of directly changing or controlling the content of internal
experiences, as CBT does. ACT has received support for its effectiveness in chronic pain but
there are very few clinical randomized trials to compare it with traditional CBT.
The purpose of this study is to determine whether an ACT-based intervention when compared
with a CBT-based intervention designed for chronic pain patients is efficacious in reducing
pain interference, pain-related disability, and psychological distress. Also this study aims
to examine whether any therapeutic effects result due to the effect of acceptance, for those
participating in the ACT group or control appraisal, for those participating in the CBT
group. Better knowledge of the mechanism of therapeutic change can help us to recognize
which patients can be benefit from which approach.
| Status | Active, not recruiting |
| Enrollment | 200 |
| Est. completion date | July 2016 |
| Est. primary completion date | June 2016 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 70 Years |
| Eligibility |
Inclusion Criteria: - Presentation of chronic pain episodes - Significant impact of the chronic pain condition on quality of life - Having a medical diagnosis of chronic pain - Stable medical treatment for at least 2 months - Reading ability sufficient to comprehend self-monitoring forms as well as competence in the Greek language Exclusion Criteria: - An active non pharmacologically-controlled psychotic spectrum condition or manic episode, suicidal ideation/ intent or substance use problems within the 6 months prior to recruitment - Having a severe medical condition in the present (e.g. cancer) - No significant cognitive impairment, as assessed using the Mini-mental Status Examination (MMSE). - Age under 18 or above 70 years - Receiving any other psychological intervention which is based on CBT |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Greece | University of Crete | Rethymnon | Crete |
| Lead Sponsor | Collaborator |
|---|---|
| University of Cyprus | University of Crete |
Greece,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Changes in the levels of pain acceptance as assessed via the Greek Chronic Pain Acceptance Questionnaire (G-CPAQ; Vasiliou, Karekla, Michaelides, & Kasinopoulos, under review) | The G-CPAQ assesses pain acceptance and consists of 20 items (long version) of which 8-items comprise the short version. It is rated on a 7-point Likert scale (0 = "never true" to 6 = "always true") and yields a total sum with a range from 0-120. Higher scores denote greater pain acceptance. The G-CPAQ presents with sufficient construct validity when assessed with scales considered theoretically related and appears with high reliability (Cronbach's alpha: Total score = .76; AE =.86; PW = .69 for the G-CPAQ-8). | Changes in pain acceptance from baseline through study completion, an average of 1 year | No |
| Other | Changes in avoidance of pain levels as assessed via the Greek version of the Psychological Inflexibility in Pain Scale (G-PIPS-II; Vasiliou, Karekla, Michaelides, & Kasinopoulos, in preparation; Wicksell, Lekander, Sorjonen & Olsson, 2010) | The G-PIPS-II contains 12 items assessing pain-related avoidance. Items are rated on a 7-point Likert-type scale, with 1="never true" and 7="always true". Higher scores indicate higher avoidance of pain. The scale shows good psychometric properties (Wicksell et al. 2010) with high internal consistency (Cronbach's a=.88) and validity with associated constructs in its Greek version. The PIPS-II scale is frequently used a a coping with pain scale assessing pain avoidance. | Changes in pain avoidance from baseline through study completion, an average of 1 year | No |
| Other | Changes in experiential avoidance as assessed via the Acceptance and Action Questionnaire- Greek version (AAQ-II; Karekla & Michaelides, under review) | The Acceptance and Action Questionnaire- Greek version is a 7-item measure of experiential avoidance or an individual efforts to systematically avoid or control unwanted internal experiences such as thoughts, emotions, bodily sensations etc (Hayes et al, 2004). It uses a Likert-type scale ranging from 1="never true" to 7="always true". Higher scores indicate greater experiential avoidance. The measure demonstrated good psychometric properties (Cronbach's alpha=.83) and a unidimensional factor structure in its original version (Bond et al., 2011). Also, validation of the AAQ-II in the Greek language present with similar with its english counterpart psychometric properties (alpha=.92). | Changes in experiential avoidance from baseline through study completion, an average of 1 year | No |
| Other | Changes in mindfulness as assessed via the Cognitive Affective Mindfulness Scale-Revised (CAMS-R; Feldman, Hayes, Kumar, Greeson, & Laurenceau, 2007) | The CAMS-R is a 12 item questionnaire assessing mindfulness. Items are rated on a 4-point Likert scale from 1="rarely" to 4="almost always". Cronbach's alpha ranges from .74 to .77 (Feldman et al., 2007). CAMS-R presents with high reliability (a = .81) and sufficient construct validity as assessed with theoretically related constructs. A Greek version appears with similar to its English counterpart unitary factor structure, high reliability (a =.88) and sufficient construct validity with other theoretically-related scales. | Changes in mindfulness levels from baseline through study completion, an average of 1 year | No |
| Other | Changes in goal-directed behaviors as assessed via the Committed Action Questionnaire (CAQ; McCracken et al., 2014) | CAQ is an 8-item scale assesses goals- directed behaviors (McCracken, 2014). Items are ranged from 0 = never true to 6 = always true, and higher scores denote higher committed actions. CAQ presents with high internal consistency reliability (a = .87) and sufficient validity with other related instruments, including pain acceptance, depression, and functioning (McCracken et al., 2014). | Changes in goal-directed behaviors from baseline through study completion, an average of 1 year | No |
| Other | Changes in living composite values as assessed via the Valued Living Questionnaire (VLQ; Wilson, Sandoz, Kitchens, & Roberts, 2010) | VLQ assesses individuals' values and the degree to which they live consistently with these values in their everyday life. It consists of two factors (i.e. importance and consistency). Respondents are asked to rate 10 areas of life (e.g. family, relationships, work, education etc.) on a scale of 1= the worst level of important/ consistency in each domain and 10= the highest level of importance/ consistency in each domain. The living composite which represents the degree to which a person lives and behaves in accordance to chosen values, is calculated by summing the importance and consistency responses for each item (Wilson, 2008). Preliminary studies demonstrate that the VLQ has adequate reliability a = .74 (Wilson et al., 2010). Reliability of the Greek version of the VLQ is high for both factors (Importance: a = .81; Consistency: a =.87) and the living composite total score (a =.89; Stavrinaki, Siamata, Vasiliou, Karekla & Kasinopoulos, 2013). | Changes in living composite values levels from baseline through study completion, an average of 1 year | No |
| Primary | Change in pain intensity as assessed with the Greek Brief Pain Inventory (G-BPI) | is an 11-item measure of intensity and interference of pain in 7 life dimensions: work, mood, activity, sleep, relationships, walking and enjoyment, rated on a scale with 0="no pain" and 10="pain as bad as you can imagine". The G-BPI has shown good reliability, Cronbach's alpha=.80 and sufficient validity with constructs considered theoretically related. | Change from baseline pain intensity through study completion, an average of 1 year | No |
| Secondary | Change in the Quality of life as assessed with the Short Form Health Survey (SF-36; Greek version 1.0; Pappa, Kontodimopoulos & Niakas, 2005) | The SF-36 is a 36 items multipurpose measure assessing physical and mental health indexes. It yields a total score indicating a general health index. SF-36 uses a Likert-type scale and higher scores indicate better overall quality of life. The SF-36 is widely used in clinical studies and evidence across studies indicate that it presents with high validity when compared with theoretically related scales. Also across studies SF-36 yields sufficinet chronbach alpha reliability. | Change in levels of QoL from baseline through study completion, an average of 1 year | No |
| Secondary | Change in insomnia as assessed with the Athens Insomnia Scale (AIS; Soldatos, Digeos, Paparrigopoulos, 2000) | The AIS is an 8 item scale assessing difficulty with sleep induction, awakenings during the night, early morning awakening, total sleep time, and overall quality of sleep. It uses a Likert-type scale with items ranging from 0= no problem at all to 3= serious problem. AIS has a long and brief version.The long version utilizes the entire eight-item scale (AIS-8) with a total score ranging from 0 (i.e., absence of any sleep-related problem) to 24 (i.e. the most severe degree of insomnia) and assesses a full range of insomnia symptoms reflecting the disorder as it is described in the ICD-10. The brief five-item version (AIS-5) is limited to the first five items, and yields a total score ranged from 0 to 15. AIS-5 evaluates difficulties with sleep quantity and quality. The AIS (both versions) demonstrates good convergent validity when assessed with theoretically related scales and excellent reliability (a=.89 for the AIS-8 and a=.88 for the AIS-5). | Change in insomnia from baseline through study completion, an average of 1 year | No |
| Secondary | Change in the levels of psychological distress as assessed with the Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) | HADS is a 14 item questionnaire assessing levels of anxiety and depression symptomatology. Each subscale consists of 7 items rated on a 4-point scale (0-3). Higher scores indicate greater psychological distress. The Greek version presents with high internal consistency (Cronbach's alpha=.88) and sufficient validity when compared with scales considered theoretically related (Michopoulos et al., 2008). | Changes in the levels of psychological distress from baseline through study completion, an average of 1 year | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|